Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-01 Sale | 2026-04-03 07:31 am | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 3,500 | $2.2 | $7,700 | 102,000 (Direct) | View |
| 2026-04-01 Sale | 2026-04-03 07:29 am | COMPUGEN LTD | CGEN | Ophir Eran President and CEO | 5,625 | $2.2067 | $12,413 | 35,750 (Direct) | View |
| 2026-03-26 Sale | 2026-03-30 6:04 pm | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 11,875 | $2.0368 | $24,187 | 45,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-01 Exercise | 2026-04-03 07:31 am | N/A N/A | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 1,000 | $1.15 | 102,000 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 07:31 am | N/A N/A | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 2,500 | $0.8292 | 102,000 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 07:31 am | N/A 2032-11-09 | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 3,500 | $0 | 102,000 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 07:29 am | N/A N/A | COMPUGEN LTD | CGEN | Ophir Eran President and CEO | 5,625 | $0.8292 | 35,750 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-03 07:29 am | N/A 2032-11-09 | COMPUGEN LTD | CGEN | Ophir Eran President and CEO | 5,625 | $0 | 35,750 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-30 6:04 pm | N/A N/A | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 11,875 | $0.8292 | 45,500 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-30 6:04 pm | N/A 2032-11-09 | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 11,875 | $0 | 45,500 (Direct) | View |
Ownership | 2026-03-18 06:32 am | N/A N/A | COMPUGEN LTD | CGEN | ZWEIFACH SANFORD S Director | 0 | $0 | 92,680 (Direct) | View |
Ownership | 2026-03-18 06:27 am | N/A N/A | COMPUGEN LTD | CGEN | Silberman David Chief Financial Officer | 0 | $0 | 124,500 (Direct) | View |
Ownership | 2026-03-18 06:23 am | N/A N/A | COMPUGEN LTD | CGEN | Livnat Savitzky Kinneret Director | 0 | $0 | 128,350 (Direct) | View |
Ownership | 2026-03-18 06:20 am | N/A N/A | COMPUGEN LTD | CGEN | Perry Eran Director | 0 | $0 | 115,000 (Direct) | View |
Ownership | 2026-03-18 06:19 am | N/A N/A | COMPUGEN LTD | CGEN | Ophir Eran President and CEO | 0 | $0 | 561,625 (Direct) | View |
Ownership | 2026-03-18 06:11 am | N/A N/A | COMPUGEN LTD | CGEN | Mahler Michelle Chief Medical Officer | 0 | $0 | 116,875 (Direct) | View |
Ownership | 2026-03-18 06:10 am | N/A N/A | COMPUGEN LTD | CGEN | Levine Zurit SVP, Business Development | 0 | $0 | 533,625 (Direct) | View |
Ownership | 2026-03-18 06:09 am | N/A N/A | COMPUGEN LTD | CGEN | Hukkelhoven Mathias Director | 0 | $0 | 85,000 (Direct) | View |
Ownership | 2026-03-18 06:08 am | N/A N/A | COMPUGEN LTD | CGEN | Holcomb Michele Director | 0 | $0 | 35,000 (Direct) | View |
Ownership | 2026-03-18 06:07 am | N/A N/A | COMPUGEN LTD | CGEN | Halevy Gilead Director | 0 | $0 | 126,407 (Direct) | View |
Ownership | 2026-03-18 06:06 am | N/A 2031-07-27 | COMPUGEN LTD | CGEN | Ferre Pierre Chief Operating Officer | 0 | $0 | 400,000 (Direct) | View |
Ownership | 2026-03-18 06:04 am | N/A N/A | COMPUGEN LTD | CGEN | Cohen-Dayag Anat Director | 0 | $0 | 1,623,622 (Direct) | View |
Ownership | 2026-03-18 06:03 am | N/A N/A | COMPUGEN LTD | CGEN | Kredo Russo Sharon SVP, Research & Discovery | 0 | $0 | 45,500 (Direct) | View |